Speech-Language Pathologists in Wayne, WV Accepting Medicare

5 Speech-Language Pathologists found. Showing 1 - 5

Ms. Shea L Ashworth, SLP-MA-CCC-S Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 212 North Court St, Wayne, WV 25570 Phone: 304-272-5116    Fax: 304-272-5993

Mrs. Tammy Lynn May Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 212 North Court St, Wayne, WV 25570 Phone: 304-272-5116

Emily Bumgardner Franks Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 212 North Court St., Wayne, WV 25570 Phone: 304-272-5116

Mrs. Amanda Caines Brooks, MS-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Rr 2 Box 2221, Wayne, WV 25570 Phone: 304-962-4133

Ms. Christine Sanders Kelly, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 212 North Court Street, Wayne, WV 25570 Phone: 304-272-5116    Fax: 304-272-5993

News Archive

HIV-1 Tat expression leads to perturbations in cellular protein expression, research suggests

The cover for issue 54 of Oncotarget features Figure 2, "Comparative proteomic profiling of the peptides/proteins identified from 293T, IL16lamp2b and mExo-Tat samples," by Lu, et al.

Study evaluates how eating habits could impact obesity trends among adults

Too much fast food, poor meal choices and bad eating habits are causing more Canadians to be overweight or obese. Despite this trend, individuals who eat well are 20 per cent less likely to be obese, according to a study by Concordia University economists published in the Journal of Primary Care & Community Health.

Synta announces interim results from docetaxel Phase 2b/3 trial on NSCLC

Synta Pharmaceuticals Corp. announced today that interim results from the Phase 2b/3 GALAXY trial will be presented at the Chemotherapy Foundation Symposium in New York City on Friday, November 9 during the 11:45 a.m. session on new agents for lung cancer. Presenting this data at the conference will be Dr. Suresh Ramalingham, Professor, Hematology & Medical Oncology, and Director, Translational Thoracic Malignancies Program, of the Winship Cancer Institute of Emory University.

Two new methods could accelerate development of improved antisense drugs

Powerful antisense drugs that target disease-associated genes to block their expression can be used to treat a broad range of diseases. Though antisense therapy has been proven effective, challenges remain in ensuring that the drugs reach their intended targets.

Childhood diarrhea from pathogens more common than previously thought?

The number of cases of childhood diarrhea, and its mortality toll of 500,000 per year, has not changed. Now, however, we can explain ~90% of the cases to specific pathogens. We can assign responsibility.

Read more Medical News

› Verified 5 days ago